Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Rob Boer
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Activities & Behaviors
Geographic Areas
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
23
de Koning, Harry
16
Habbema, Dik
14
van Ballegooijen, Marjolein
14
van Oortmarssen, Gerrit
11
van der Maas, Paul
8
Warmerdam, PG
7
Beemsterboer, PM
6
Hendriks, J H C L
6
Loeve, Franka
6
Fracheboud, Jacques
6
van Ineveld, Martin
6
Verbeek, André
5
Zauber, Ann
4
Draisma, Gerrit
3
Broeders, M J M
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Rob Boer (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lansdorp-Vogelaar Iris; van Ballegooijen Marjolein; Zauber Ann G; Boer Rob; Wilschut Janneke; Winawer Sidney J; Habbema J Dik F
Individualizing colonoscopy screening by sex and race.
Gastrointestinal endoscopy 2009;70(1):96-108, 108.e1-24.
-
2009: Lansdorp-Vogelaar Iris; van Ballegooijen Marjolein; Boer Rob; Zauber Ann; Habbema J Dik F
A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.
Cancer 2009;115(11):2410-9.
-
2009: Lansdorp-Vogelaar Iris; van Ballegooijen Marjolein; Zauber Ann G; Boer Rob; Wilschut Janneke; Habbema J Dik F
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.
International journal of cancer. Journal international du cancer 2009;124(5):1161-8.
-
2009: Rebolj Matejka; van Ballegooijen Marjolein; Lynge Elsebeth; Looman Caspar; Essink-Bot Marie-Louise; Boer Rob; Habbema Dik
Incidence of cervical cancer after several negative smear results by age 50: prospective observational study.
BMJ (Clinical research ed.) 2009;338():b1354.
-
2008: Rebolj Matejka; van Ballegooijen Marjolein; van Kemenade Folkert; Looman Caspar; Boer Rob; Habbema J Dik F
No increased risk for cervical cancer after a broader definition of a negative Pap smear.
International journal of cancer. Journal international du cancer 2008;123(11):2632-5.
-
2008: de Gelder Rianne; van As Elisabeth; Tilanus-Linthorst Madeleine M A; Bartels Carina C M; Boer Rob; Draisma Gerrit; de Koning Harry J
Breast cancer screening: evidence for false reassurance?
International journal of cancer. Journal international du cancer 2008;123(3):680-6.
-
2007: Rebolj Matejka; Bais Aagje G; van Ballegooijen Marjolein; Boer Rob; Meerding Willem-Jan; Helmerhorst Theo J M; Habbema J Dik F
Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies.
International journal of cancer. Journal international du cancer 2007;121(7):1529-35.
-
2007: Boer Rob; Zheng Yuhui; Overton Adrian; Ridgeway Gregory K; Cohen Deborah A
Neighborhood design and walking trips in ten U.S. metropolitan areas.
American journal of preventive medicine 2007;32(4):298-304.
-
2006: Lim Yee-Wei; Steinhoff Mark; Girosi Federico; Holtzman Douglas; Campbell Harry; Boer Rob; Black Robert; Mulholland Kim
Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics.
Nature 2006;444 Suppl 1():9-18.
-
2006: Girosi Federico; Olmsted Stuart S; Keeler Emmett; Hay Burgess Deborah C; Lim Yee-Wei; Aledort Julia E; Rafael Maria E; Ricci Karen A; Boer Rob; Hilborne Lee; Derose Kathryn Pitkin; Shea Molly V; Beighley Christopher M; Dahl Carol A; Wasserman Jeffrey
Developing and interpreting models to improve diagnostics in developing countries.
Nature 2006;444 Suppl 1():3-8.
-
2006: Vogelaar Iris; van Ballegooijen Marjolein; Schrag Deborah; Boer Rob; Winawer Sidney J; Habbema J Dik F; Zauber Ann G
How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment.
Cancer 2006;107(7):1624-33.
-
2006: Fracheboud Jacques; Groenewoud Johanna Helëne; Boer Rob; Draisma Gerrit; de Bruijn Arry E; Verbeek André L M; de Koning Harry J
Seventy-five years is an appropriate upper age limit for population-based mammography screening.
International journal of cancer. Journal international du cancer 2006;118(8):2020-5.
-
2006: Clarke Lauren D; Plevritis Sylvia K; Boer Rob; Cronin Kathleen A; Feuer Eric J
A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.
Journal of the National Cancer Institute. Monographs 2006;(36):96-105.
-
2006: Tan Sita Y G L; van Oortmarssen Gerrit J; de Koning Harry J; Boer Rob; Habbema J Dik F
The MISCAN-Fadia continuous tumor growth model for breast cancer.
Journal of the National Cancer Institute. Monographs 2006;(36):56-65.
-
2006: Bhatnagar Vibha; Stoto Michael A; Morton Sally C; Boer Rob; Bozzette Samuel A
Transmission patterns of smallpox: systematic review of natural outbreaks in Europe and North America since World War II.
BMC public health 2006;6():126.
-
2004: Boer Rob; Plevritis Sylvia; Clarke Lauren
Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.
Statistical methods in medical research 2004;13(6):525-38.
-
2004: Loeve Franka; Boer Rob; Zauber Ann G; Van Ballegooijen Marjolein; Van Oortmarssen Gerrit J; Winawer Sidney J; Habbema J Dik F
National Polyp Study data: evidence for regression of adenomas.
International journal of cancer. Journal international du cancer 2004;111(4):633-9.
-
2004: Loeve F; van Ballegooijen M; Boer R; Kuipers E J; Habbema J D F
Colorectal cancer risk in adenoma patients: a nation-wide study.
International journal of cancer. Journal international du cancer 2004;111(1):147-51.
-
2004: Rijnsburger Adriana J; van Oortmarssen Gerrit J; Boer Rob; Draisma Gerrit; To Teresa; Miller Anthony B; de Koning Harry J
Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation.
International journal of cancer. Journal international du cancer 2004;110(5):756-62.
-
2003: Draisma Gerrit; Boer Rob; Otto Suzie J; van der Cruijsen Ingrid W; Damhuis Ronald A M; Schröder Fritz H; de Koning Harry J
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
Journal of the National Cancer Institute 2003;95(12):868-78.
-
2003: Otto Suzie J; Fracheboud Jacques; Looman Caspar W N; Broeders Mireille J M; Boer Rob; Hendriks Jan H C L; Verbeek André L M; de Koning Harry J;
Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.
Lancet 2003;361(9367):1411-7.
-
2003: Bozzette Samuel A; Boer Rob; Bhatnagar Vibha; Brower Jennifer L; Keeler Emmett B; Morton Sally C; Stoto Michael A
A model for a smallpox-vaccination policy.
The New England journal of medicine 2003;348(5):416-25.
-
2002: Etzioni Ruth; Penson David F; Legler Julie M; di Tommaso Dante; Boer Rob; Gann Peter H; Feuer Eric J
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
Journal of the National Cancer Institute 2002;94(13):981-90.
-
2002: de Koning Harry J; Liem Michael K; Baan Caroline A; Boer Rob; Schröder Fritz H; Alexander Freda E;
Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial.
International journal of cancer. Journal international du cancer 2002;98(2):268-73.
-
2002: van den Akker-van Marle M Elske; van Ballegooijen Marjolein; van Oortmarssen Gerrit J; Boer Rob; Habbema J Dik F
Cost-effectiveness of cervical cancer screening: comparison of screening policies.
Journal of the National Cancer Institute 2002;94(3):193-204.
-
2001: Hoedemaeker R F; van der Kwast T H; Boer R; de Koning H J; Roobol M; Vis A N; Schröder F H
Pathologic features of prostate cancer found at population-based screening with a four-year interval.
Journal of the National Cancer Institute 2001;93(15):1153-8.
-
2001: Loeve F; Boer R; van Oortmarssen G J; van Ballegooijen M; Habbema J D
Impact of systematic false-negative test results on the performance of faecal occult blood screening.
European journal of cancer (Oxford, England : 1990) 2001;37(7):912-7.
-
2001: Fracheboud J; de Koning H J; Boer R; Groenewoud J H; Verbeek A L; Broeders M J; van Ineveld B M; Hendriks J H; de Bruyn A E; Holland R; van der Maas P J;
Nationwide breast cancer screening programme fully implemented in The Netherlands.
Breast (Edinburgh, Scotland) 2001;10(1):6-11.
-
2000: Loeve F; Brown M L; Boer R; Habbema J D
Re: improving the cost-effectiveness of colorectal cancer screening.
Journal of the National Cancer Institute 2000;92(20):1691-2.
-
2000: Connor R J; Boer R; Prorok P C; Weed D L
Investigation of design and bias issues in case-control studies of cancer screening using microsimulation.
American journal of epidemiology 2000;151(10):991-8.
-
2000: Loeve F; Brown M L; Boer R; van Ballegooijen M; van Oortmarssen G J; Habbema J D
Endoscopic colorectal cancer screening: a cost-saving analysis.
Journal of the National Cancer Institute 2000;92(7):557-63.
-
1999: Fracheboud J; de Koning H J; Beemsterboer P M; Boer R; Verbeek A L; Hendriks J H; van Ineveld B M; Broeders M J; de Bruyn A E; van der Maas P J
Interval cancers in the Dutch breast cancer screening programme.
British journal of cancer 1999;81(5):912-7.
-
1999: Boer R; de Koning H J; van der Maas P J
A longer breast carcinoma screening interval for women age older than 65 years?
Cancer 1999;86(8):1506-10.
-
1999: van den Akker-van Marle M E; van Ballegooijen M; Boer R; van Oortmarssen G J; Habbema J D
Withdrawing low risk women from cervical screening programmes. Conclusions cannot yet be drawn.
BMJ (Clinical research ed.) 1999;319(7201):58.
-
1999: Boer R; Schröder F H
Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction.
The Prostate 1999;40(2):130-4.
-
1999: Loeve F; Boer R; van Oortmarssen G J; van Ballegooijen M; Habbema J D
The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening.
Computers and biomedical research, an international journal 1999;32(1):13-33.
-
1999: Boer R; de Koning H; van Oortmarssen G; Warmerdam P; van der Maas P
Stage distribution at first and repeat examinations in breast cancer screening.
Journal of medical screening 1999;6(3):132-8.
-
1999: van den Akker-van Marle E; de Koning H; Boer R; van der Maas P
Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom.
Journal of medical screening 1999;6(1):30-4.
-
1998: van Ballegooijen M; Beck S; Boon M E; Boer R; Habbema J D
Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.
Acta cytologica 1998;42(5):1133-8.
-
1998: Boer R; de Koning H; Threlfall A; Warmerdam P; Street A; Friedman E; Woodman C
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
BMJ (Clinical research ed.) 1998;317(7155):376-9.
-
1998: Fracheboud J; de Koning H J; Beemsterboer P M; Boer R; Hendriks J H; Verbeek A L; van Ineveld B M; de Bruyn A E; van der Maas P J
Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.
International journal of cancer. Journal international du cancer 1998;75(5):694-8.
-
1998: Beemsterboer P M; Warmerdam P G; Boer R; de Koning H J
Radiation risk of mammography related to benefit in screening programmes: a favourable balance?
Journal of medical screening 1998;5(2):81-7.
-
1997: van den Akker-van Marle M E; Reep-van den Bergh C M; Boer R; Del Moral A; Ascunce N; de Koning H J
Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.
International journal of cancer. Journal international du cancer 1997;73(4):464-9.
-
1997: Boer R; de Koning H J; Beemsterboer P M; Warmerdam P G; Schroeder F H
A comparison of disease specific survival of patients who died of and who had newly diagnosed prostate cancer.
The Journal of urology 1997;157(5):1768-71; discussion 1771-2.
-
1997: Warmerdam P G; de Koning H J; Boer R; Beemsterboer P M; Dierks M L; Swart E; Robra B P
Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
Journal of epidemiology and community health 1997;51(2):180-6.
-
1996: Boer R; van Oortmarssen G J; de Koning H J
Cost-effectiveness of mammography screening.
JAMA : the journal of the American Medical Association 1996;275(2):111-2.
-
1995: Boer R; de Koning H J; van Oortmarssen G J; van der Maas P J
In search of the best upper age limit for breast cancer screening.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):2040-3.
-
1995: de Koning H J; Boer R; Warmerdam P G; Beemsterboer P M; van der Maas P J
Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
Journal of the National Cancer Institute 1995;87(16):1217-23.
-
1995: Boer R; De Koning H J; van Oortmarssen G J; van der Maas P J
Screening for breast cancer. Incidence of interval cancer and detection rate of first screenings are inconsistent.
BMJ (Clinical research ed.) 1995;310(6985):1002.
-
1995: De Koning H J; Fracheboud J; Boer R; Verbeek A L; Collette H J; Hendriks J H; van Ineveld B M; de Bruyn A E; van der Maas P J
Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).
International journal of cancer. Journal international du cancer 1995;60(6):777-80.
-
1995: van Oortmarssen G J; Boer R; Habbema J D
Modelling issues in cancer screening.
Statistical methods in medical research 1995;4(1):33-54.
-
1995: Paci E; Boer R; Zappa M; de Koning H J; van Oortmarssen G J; Crocetti E; Giorgi D; Rosselli del Turco M; Habbema J D
A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy.
European journal of cancer (Oxford, England : 1990) 1995;31A(3):348-53.
-
1994: Beemsterboer P M; de Koning H J; Warmerdam P G; Boer R; Swart E; Dierks M L; Robra B P
Prediction of the effects and costs of breast-cancer screening in Germany.
International journal of cancer. Journal international du cancer 1994;58(5):623-8.
-
1994: Boer R; Warmerdam P; de Koning H; van Oortmarssen G
Extra incidence caused by mammographic screening.
Lancet 1994;343(8903):979.
-
1993: Carter R; Glasziou P; van Oortmarssen G; de Koning H; Stevenson C; Salkeld G; Boer R
Cost-effectiveness of mammographic screening in Australia.
Australian journal of public health 1993;17(1):42-50.
-
1993: van Ineveld B M; van Oortmarssen G J; de Koning H J; Boer R; van der Maas P J
How cost-effective is breast cancer screening in different EC countries?
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1663-8.
-
1990: de Koning H J; Boer R; van der Maas P J; van Ineveld B M; Collette H J; Hendriks J H
[Efficacy of mass screening for breast cancer; reduced mortality nationally and internationally]
Nederlands tijdschrift voor geneeskunde 1990;134(46):2240-5.
Sign-in to see more
